Augmented Berlin-Frankfurt-Munster (BFM) Therapy for Adolescent/Young Adults With Acute Lymphoblastic Leukemia or Acute Lymphoblastic Lymphoma

Starting Dose 25 mg/m\^2 by vein weekly

Starting Dose 2 mg by vein weekly

Starting Dose 2000 International units/m2 by vein in week 1

Starting Dose 12 mg on week 2 and week 5 injected into spinal fluid

Starting Dose 1g/m2 by vein in weeks 1 and 5

75 mg/m2 subcutaneous or by vein for four consecutive days on days 1-4 and days 8-11 of both months

Starting Dose 60 mg/m2 by mouth on days 1-14 of each month

"Starting Dose at 100 mg/m2 by vein and escalating by 50 mg/m2/dose every 10~+/- 2 days for 5 doses to toxicity (e.g myelosuppression or mucositis grade 3"

25 mg/m2 by vein in weeks 1, 2 and 3

60 mg/m2 by mouth daily for two weeks